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Abstract
An abnormal plasma polyunsaturated fatty
acid pattern (PUFA) (increased n3 and de-
creased n6 PUFA) has been reported in active
inflammatory bowel disease (IBD). The possi-
bility of a primary defect in the PUFA meta-
bolism in IBD was hypothesised. The aim of
this study was to assess plasma PUFA pattern
in inactive inflammatory bowel disease and to
ascertain whether patients who had had a
colectomy and who were suffering from ulcer-
ative colitis have a similar PUFA pattern than
those patients with non-active ulcerative
colitis and who had not had a colectomy.
Plasma fatty acids were analysed by semi-
capillary column gas-liquid chromatography in
three groups of patients with inactive IBD (24
patients with inactive ulcerative colitis who
had not had a colectomy, 15 patients with
ulcerative colitis who had had a colectomy,
and 27 patients with Crohn's disease). Plasma
concentration and percentage of C22:6n3 and
unsaturation index were significantly higher in
patients with inactive ulcerative colitis without
a colectomy and the Crohn's disease group
(p<0O0001) than in controls. Plasma concen-
tration and percentage of C22:6n3 and the
unsaturation index remained significantly
higher, in both the operated and non-operated
ulcerative colitis patients when compared with
controls (p<00001). These results suggest
that in inactive IBD, an increased PUFA bio-
synthesis might be the cause ofthe high values
of n3 compounds. These findings although
seen in active disease, are more noticeable in
remission because of the lack of artefactual
factors (malnutrition, steroids, inflammation).
In addition, persistence of high values in both
groups of ulcerative colitis patients - that is,
those who had had a colectomy and those who
had not suggests the existence of a primary
abnormality in the PUFA metabolism in IBD.
(Gut 1993; 34: 1370-1373)
Polyunsaturated fatty acids (PUFA) participate
in membrane function,'2 including that of the
immune cells34 and they are precursors of the
eicosanoids.'-8 For these reasons, they may play
an important part in the pathogenesis of inflam-
matory bowel disease (IBD).
We have described an abnormal PUFA pat-
tern in active IBD.9 This consists of increased
values of the precursor (C18:3n3) and the end
product (C22;6n3) of the n3 series and decreased
values ofdihommo-y-linolenic acid (C20:3n6). A
stepwise decrease in PUFA values, which was
more noticeable for the n6 series was also seen as
the disease became more severe. Even in severe
disease, however, plasma concentrations of the
n3 PUFA remained higher than those in healthy
controls. These findings suggested that in IBD
there might be a primary increase in PUFA
biosynthesis. In active IBD this phenomenon
would be partly counterbalanced by an increased
fatty acid utilisation because of factors associated
with disease activity, such as inflammation,
hypermetabolism, malnutrition, and steroid
treatment.
On the basis of the above findings, it could be
hypothesised that in the absence ofother factors,
that is in inactive disease, the values oflong chain
PUFA would be even higher. Therefore, the
study of patients with inactive IBD would be of
interest. In addition, to ascertain the possible
existence of a primary defect in PUFA meta-
bolism, the study of patients with ulcerative
colitis who had had a colectomy would be
particularly important, as in such patients, the
target organ has been removed. The aim of this
study was to assess prospectively the plasma
fatty acid pattern in patients with inactive IBD
(both ulcerative colitis and Crohn's disease), and
in ulcerative colitis patients after colectomy.
Patients and methods
PATIENTS
Three groups of 66 patients with inactive IBD
were included in the study: 27 Crohn's disease
(16 men, 11 women; median age 24 years; ranges
14-78 years), 24 ulcerative colitis patients (10
men, 14 women; median age 41 years; range:
23-75 years) and 15 patients with ulcerative
colitis who had had a colectomy, four procto-
TABLE I Clinicalfeatures ofthe patients
Patients with Patients with
UC (no UC
colectomy) (colectomy) CD
(n=24) (n=15) (n=27)
Location ofthe disease in
previous attacks
Ulcerative colitis
Rectum 6
Left colon 12
Universal 6 15
Crohn's disease
Small bowel 7
Colon 11
Ileum+colon 9
Current drug treatment
Metronidazole 0 2 4
Sulphasalazine 16 0 9
5-ASA 8 0 4
Nutritional state'2
Well nourished 23 12 24
Kwashiorkor like 0 1 2
Marasmus 1 2 1
Mixed malnutrition 0 0 0
UC=ulcerative colitis, CD=Crohn's disease.
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TABLE II Plasmafatty acids in inactive inflammatory bowel disease
pnolldl UC (n=24) CD (n=27) Controls (n= 107) p
16:0* 155 6 (6-1) 126-0 (4 9) 128-9(3 4) 0-0012tll16:1t 8 5 (6-6-12-9) 10-8 (6-8-15-3) 8-4(8-1-9-5) 0-5641
18:0* 60-1 (2 8) 51-9 (2 3) 53 2(1-3) 0-0649
18:1* 118-3 (7 0) 104-2 (5 4) 110-6(3 2) 0-3042
18:2n6* 169-1 (9-0) 138-4 (6 5) 137-6(3 9) 0 0030t
18:3n3t 2-1 (0 0-5 9) 0-0 (0 0-5-5) 0 0 (0 0-0 0) 0 0499t
18:3n6t 0 0 (0-0-1-6) 0 0 (0-0-1-8) 0 0 (0 0-0 0) 0-2223
20:2n6t 0 5 (0-0-2-1) 0 0 (0 0-2-2) 1-0(0 0-1 8) 0-9429
20:3n6* 15 6 (0 9) 13 7 (0 8) 13 3 (0 5) 0-1212
20:4n6* 52 0 (2 6) 43-6 (1-9) 40-6(1-4) 0-0021t
20:5n3t 1-8 (0-0-3;1) 1-3 (0 0-2-7) 0-7(0-0-1-7) 0-6049
22:6n3* 16-75(11-71-19.75) 11 6(11 17-19 68) 7-0(6-1-7-9) <0o00001ts
*Mean (SEM). One way ANOVA+Scheffe test; tmedian (95% CI), Kruskall-Wallis test+Mann-
Whitney U test; tUC v controls; §CD v controls; ||CD v UC. Other abbreviations as in Table I.
TABLE III Plasmafatty acids in inactive inflammatory bowel disease
% UC (n=24) CD (n=27) Controls (n= 107) p
16:0* 25-7 (0-3) 24-3 (0 4) 25-2 (0-2) 0-0515
16:It 1 4(0 9-2 1) 2 2(1 3-3 1) 1 7(1 5-1 9) 0 1456
18:0* 9-9(0-2) 10-0(0 3) 10-5 (0-1) 0-0811
18:1* 19 4(0-7) 20-0(0 6) 21-7(0-3) 0-0061t
18:2n6* 27-8 (0 9) 26-9 (1-0) 27-2 (0 4) 0-7817
18:3n3t 0 3 (0-0-1-0) 0 0 (0 0-0 9) 0 0 (0 0-0 0) 0-0815
18:3n6t 0 0 (0 0-0 2) 0 0 (0-0-0-3) 0 0 (0 0-0 0) 0-2480
20:2n6t 0-1 (0-0-0-3) 0 0 (0 0-0-4) 0-1 (0-0-0-3) 0-5297
20:3n6* 2-5(0-1) 2 6(0 1) 2-6(0 1) 0-9068
20:4n6* 8-6 (0-3) 8-4 (0-3) 8-0 (0-2) 0-4427
20:5n3t 0-2 (0 0-0-5) 0-2 (0 0-0 6) 0-2 (0-0-0-3) 0-8298
22:6n3t 2-6(1-9-3.5) 2-4(2 3-3 3) 1-4(1-3-1-6) <0-00001t§
UNID* 141-1(1-7) 140-7(1-8) 131-5(1 1) 0-00010t§
*Mean (SEM). One way ANOVA+Scheffe test; tmedian (95% CI), Kruskall-Wallis test+Mann-
Whitney U test; tUC v controls; §CD v controls. UNID=unsaturation index. Other abbreviations as
in Table I.
colectomy and 11 colectomy plus ileal pelvic
pouch (eight men, seven women; median age
31 years, range: 15-46 years). Patients were
considered inactive as assessed by the Truelove
and Witts' index'" for ulcerative colitis and
the Van Hess' index" for Crohn's disease. No
patient with ileal pelvic pouch had clinical,
endoscopic, or histological signs of pouchitis.
Table I shows the clinical features of the patients
studied. 12 The results of the fatty acid state of all
of these patients had been reported previously in
active phase.9
CONTROLS
A previously reported group of 107 healthy, well
nourished subjects (46 men, 61 women; median
age: 32 5 years; ranges 18-76 years) acted as a
control group.9
Informed consent was obtained from each
patient and healthy controls. The study was
performed in conformance with the 1975
Declaration of Helsinki ethical guidelines and
was approved by the Research and Ethical
Committees of the Hospital.
PLASMA FATTY ACID ASSAY
In all patients and healthy controls, a 5 ml venous
blood sample for plasma fatty acid measurement
was taken after a 14 hour overnight fast. Blood
samples in all ulcerative colitis and Crohn's
disease patients were obtained three months
after they had been considered inactive and
in ulcerative colitis patients who had had a
colectomy between three to six months after
completion of all operations. The methods used
for plasma fatty acid assay have been described in
detail elsewhere.9 1' " Heptadecanoic acid
(C17:0) was added as an internal standard to
allow fatty acid concentrations in plasma total
lipids to be determined as absolute values, and
not only as percentages.
Fatty acid from 14:0 to 22:6n3 were measured.
Unidentified peaks accounted for less than 0 5%
of the total fatty acid. Results are expressed as a
total fatty acid concentration ([tmol/dl) and
as a percentage distribution of each fatty acid.
The unsaturation index (UNID) was calculated
according to the formula'5:
UNID=> (fatty acid percentagex
number of double bonds).
STATISTICAL ANALYSIS
For statistical analysis the Statistical Package for
Social Sciences SPSS/PC+ (SPSS Inc, Chicago,
Illinois, 1985) was used.'6 Variables with normal
distribution and homogeneous variance were
compared by means of parametric tests, other-
wise their non-parametric counterparts were
used. One way analysis of variance with 'a
posterior' Scheffe test or Kruskall-Wallis one
way analysis of variance by ranks were used.
When the Kruskall-Wallis test disclosed a
significant p value, the Mann-Whitney U test
was carried out to detect where the differences
occurred. Results are expressed as mean (SEM)
or median and the 95% confidence intervals
(CI)'7 for parametric and non-parametric
variables respectively. Because age distribution
was different among the groups studied and this
is a factor influencing plasma lipids,'8 the results
were adjusted for the effect of age by means of
analysis of variance using age as a covariate.
Results
PLASMA FATTY ACIDS IN INACTIVE INFLAMMATORY
BOWEL DISEASE
Tables II and III detail respectively the plasma
fatty acid concentration and the percentages of
the different fatty acids in patients with inactive
ulcerative colitis and Crohn's disease.
The most striking finding in the plasma fatty
acid profile in inactive IBD was the considerable
increase of docosahexaenoic acid (C22:6n3), the
final product of the n3 series, both in ulcerative
colitis and Crohn's disease when compared with
controls. This fact was seen when the results
were expressed either as absolute concentration
or as a percentage.
Arachidonic acid (C20:4n6), the main product
of the n6 series, showed the same tendency.
Statistical significance was only obtained, how-
ever, between the ulcerative colitis patients and
controls, when the values were expressed as
absolute plasma concentration. Absolute plasma
values of linoleic acid (C18:2n6), the essential
precursor of the n6 series, and ct-linolenic acid
(C18:3n3), the essential precursor of the n3
series, were also increased in ulcerative colitis
(Table II).
As a consequence of the increase in long chain
and highly unsaturated PUFA, the values of the
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TABLE IV Plasma fatty acids in inactive ulcerative colitis. Influence of the colectomy on the
plasma fatty acid pattern
UC patients
Operated Non-operated Controls
pmolldl (n= 15) (n=24) (n= 107) p
16:0* 121-3(7 3) 155 6(6-1) 128-9(3 4) 0 0013§11
16: It 6-6 (10-10-3) 85 (66-12-9) 8-4 (8-1-9 5) 0 1631
18:0* 52-2 (2 2) 60-1 (2 8) 53-2 (1-3) 0-0615
18: 1* 90 1 (6-6) 118 3 (7-0) 110 6 (3 2) 0 031911
18:2n6* 147-5 (8 6) 169-1 (9 0) 137-6 (3 9) 0 0037§
18:3n3t 0 0 (0 0-49) 2-1 (0-05-9) 0 0 (0 0-0 0) 0-0808
18:3n6t 0o0(00-1 9) 0-0(0-01-6) 00(00-00) 0-3176
20:2n6t 0 0(00-2 3) 0 5(00-2 1) 1-0(0-01-8) 0 7593
20:3n6* 12-7 (1-4) 15 6 (0 9) 13-3 (0-5) 0-1082
20:4n6* 45-4 (2 4) 52-0 (2 6) 40-6 (1-4) 0-0022§
20:5n3t 0 0 (00-2 3) 1-8 (00-3 1) 0 7 (00-1-7) 0 6853
22:6n3* 13-9 (96-16.1) 16-7(11-7-19-7) 7-0(6-1-7-9) <0-00001tslI
*Mean (SEM). One way ANOVA+Scheffe test; tmedian (95% CI), Kruskall-Wallis test+Mann-
Whitney U test; toperated v controls; §non-operated v controls; Iloperated v non-operated.
TABLE V Plasma fatty acids in inactive ulcerative colitis. Influence of the colectomy on the
plasma fatty acid pattern
UC patients
Operated Non-operated Controls
% (n- 15) (n=24) (n= 107) p
16:0* 24-4(0-5) 25 7(0 3) 25 2(0-2) 0-2147
16:It 1-2 (0-2-2-1) 1-4(0-9-2-1) 1-7 (1-5-1-9) 0-0236t
18:0* 10-7 (0 3) 9-9 (0 2) 10-5 (0 1) 0-2266
18:1* 18-1 (0 7) 19-4(0-7) 21-7(0-3) 0 0002#§
18:2n6* 29-9 (1-0) 27-8 (0 9) 27-2 (0-4) 0-0918
18:3n3t 0-3 (0-01-2) 0-3(0-01-0) 00 (0 0-00) 0-1199
18:3n6t 00(00-04) 0-0(00-02) 00 (00-00) 03530
20:2n6t 0 0 (0 0-0 4) 0-1 (00-003) 0-1 (00-003) 0-3782
20:3n6t 2-6 (20-3-3) 2-4 (2 2-2 9) 2 5 (2 3-2-8) 0-9194
20:4n6t 9-1 (8-3-10-6) 8-6 (7 9-99) 7-8 (7-1-8-7) 0 0625
20:5n3t 00 (00-09) 0-2 (00-05) 0-2 (00-003) 0-9017
22:6n3t 2-3 (1-8-2.8) 2-6 (1-9-3-5) 1-4 (1-3-1-6) <0o00001ts
UNID* 142-0(1-7) 141-7(1-7) 131-5(1-1) <0-OO001t§
*Mean (SEM). One way ANOVA+Scheffe test; tmedian (95% CI), Kruskall-Wallis test+Mann-
Whitney U test; toperated v controls; §non-operated v controls. UNID=unsaturation index.
UNID were also significantly high, both in
inactive ulcerative colitis and Crohn's disease,
compared with controls (Table III).
Changes in saturated and monoenoic fatty
acids depended on a diminished percentage of
oleic acid (C 18: 1n9) and an increased concentra-
tion of palmitic acid (C16:0) in ulcerative colitis
with respect to the control group and an in-
creased percentage of palmitoleic acid (C 16: 1) in
Crohn's disease (Table III).
After adjusting for age as described in the
statistical methods section, the significance of
the differences seen did not change.
INFLUENCE OF COLECTOMY FOR ULCERATIVE
COLITIS ON PLASMA FATTY ACID PATTERN
(Tables IV and V)
Plasma docosahexaenoic acid (C22:6n3), either
as a percentage or an absolute concentration, was
significantly higher both in operated and non-
operated ulcerative colitis patients when com-
pared with controls. In addition, when expressed
as plasma concentration, C22:6n3 was signific-
antly higher in non-operated than in operated
patients (Table IV). UNID was also significantly
increased in both groups of patients compared
with controls (Table V).
In the n6 series, the plasma concentration
of linoleic (C18:2n6) and arachidonic acid
(C20:4n6) was only significantly increased in
non-operated ulcerative colitis patients with
respect to the control group, although the same
trend was seen for the operated group.
The increase of plasma long chain PUFA
content in both groups of patients was associated
with a significant decrease in the percentage of
oleic acid (C 18: 1n9) in both groups of patients
and by the reduction in the percentage of
palmitoleic acid (C 16: 1n7) in operated patients
(Table V).
After adjusting for the effect of age, the results
did not change except for the oleic acid concen-
tration, which showed no differences among the
three groups (p=0 151).
Discussion
Before discussing the results of this study, an
aspect of the methods used has to be noted. Fatty
acid values in this paper are expressed both as a
percentage of the total fatty acids and as an
absolute plasma concentration. Expressing the
results as plasma concentration permitted us to
show that any change in a given fatty acid is real,
whereas its percentage may only reflect compen-
satory changes because of increases or decreases
in other fatty acids. The results, however, should
also be given as a percentage distribution. This
provides complementary information, as it helps
to ascertain whether changes in the plasma
concentrations result in variations in the relative
amounts of fatty acids - that is, in qualitative
changes of plasma lipids.
In a previous paper,9 we reported increased n3
and decreased n6 PUFA values in active IBD. It
was then hypothesised that in active IBD a
primary enhancement in PUFA synthesis co-
existed with an increased utilisation related to
the inflammatory phenomena. In this series of
inactive IBD patients, plasma n3 PUFA are also
increased. This, together with high values of n6
PUFA and UNID, in the absence of factors
associated with active disease, further supports
this hypothesis. The fact that high n3 PUFA
values occur in both active and non-active
disease can be explained because n3 series has the
highest affinity for PUFA biosynthetic enzyme
systems.920
The increase in n6 long chain PUFA is partic-
ularly noticeable in non-active, non-operated
ulcerative colitis patients, their values being
significantly higher than those in healthy
controls. Also, significantly increased values of
the precursors of both n3 (C18:3n3) and n6
(C 18:2n6) series were seen in this group of
patients. As a high intake of essential fatty acids,
particularly of a-linolenic acid (C18:3n3), was
ruled out in all cases, this finding could be
attributed to a negative feedback effect2'-23 upon
6-6 desaturase activity, caused by the excessive
amount of products of both n3 (C22:6n3) and n6
series (C20:4n6). From these data, it could be
speculated that the hypothesis of an increased
PUFA biosynthesis is more active in ulcerative
colitis than in Crohn's disease patients.
Differences in age distribution may account,
at least in part, for the differences seen in plasma
fatty acid concentrations between operated and
non-operated patients and between ulcerative
colitis patients and controls. After adjusting for
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age as a covariate, however, the significance of
the results did not change, except for oleic acid
concentration, which showed no differences
between operated and non-operated ulcerative
colitis patients.
Malnutrition may be another important factor
that explains fatty acid differences among groups
because PUFA deficiency has been described in
malnourished patients.2425 Malnutrition only
*occurred, however, in four (10%) ulcerative
colitis and three (11%) Crohn's disease patients
in this series. Moreover, vitamin and trace
element deficiencies, which have been reported
in active IBD,2627 could be additional factors
influencing PUFA biosynthesis. Unfortunately,
data on the micronutrient state in this series of
non-active patients are not available.
A further argument in favour of the existence
of an increased PUFA biosynthesis in IBD is the
persistence of increased values of docosahex-
aenoic acid (C22:6n3) three to six months after
colectomy in patients with ulcerative colitis. In
addition, this finding suggests that it may be
because of a primary metabolic defect. Although
three to six months seems to be enough time to
reach a stable state after colectomy, the possi-
bility that plasma PUFA pattern took longer to
return to normal has to be ruled out in future
studies. Thus, a study comparing larger groups
of patients with both proctocolectomy and
colectomy plus ileal pouch patients, at least two
years after the completion of surgery, has to be
performed to confirm these results.
On the other hand, the hypothesis of a
genetically determined primary defect in PUFA
metabolism in IBD should be assessed by
measuring PUFA profile in healthy relatives of
IBD patients.
These results further support our reluctance
to use long chain n3 PUFA in treatment for
either acute attacks of IBD or for maintenance
treatment of the disease.
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